Press releases

Here you can find corporate releases on topics related to governance, investments, and important announcements.

Read more

Investors

Nasdaq:

CRMD

$ 5.69 Last update: 09/07/2024 5:24:58 pm ET Time Read more

About CRBSI

Learn more about Catheter-related blood stream infections (CRBSIs) and how they affect hemodialysis central venous catheter (HD-CVC) patients.

Read more
WHY CORMEDIX

We relentlessly pursue therapeutic options to reduce and treat infectious and inflammatory disease

About us
PRESS RELEASES

Review corporate releases related to governance,
investor news, and other important announcements.

Aug 14, 2024

CorMedix Inc. Reports SECOND Quarter AND SIX MONTH 2024 Financial Results and Provides Business Update
Aug 07, 2024

CORMEDIX INC. TO REPORT SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDE A CORPORATE UPDATE ON AUGUST 14, 2024
Jul 03, 2024

CORMEDIX INC. ANNOUNCES OUTPATIENT AVAILABILITY OF DEFENCATH
Jun 18, 2024

CORMEDIX INC. RECEIVES FDA FEEDBACK ON POTENTIAL LABEL EXPANSION
Jun 06, 2024

CORMEDIX INC. ANNOUNCES CMS GRANTS PASS-THROUGH STATUS TO DEFENCATH
See all